LENEXA, Kan.--(BUSINESS WIRE)--Evogen recently announced, on March 13, 2013, that it entered into a non-exclusive sub-License Agreement with a leading national reference laboratory. For the avoidance of confusion, HyBeacon® and HyBeacons® are registered trademarks of LGC Limited, or its affiliate, and of which Evogen is a licensee. Evogen has exclusive worldwide rights for development and sale of products incorporating HyBeacons® technology that relate to detection and analysis of nucleic acid sequences for all and any purposes with the exception of forensic science and human identification and Human Pharmacogenetics.
